New cancer drug begins human testing
Disease control
Recruiting now
This is the first human study of an experimental cancer drug called PLT012. Researchers want to find the safest dose for adults with advanced solid tumors and see if it shows early signs of helping. All 36 participants will receive the drug through an IV every three weeks while d…
Phase: PHASE1 • Sponsor: Pilatus Biosciences Inc • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC